Sector: MedicalMedarex, Inc. (NASDAQ: MEDX)
Headlines
- Big Pharma And Biotech - Industry Outlook
Nov 09, 2009 06:03 PM | ABT, ACL, ACOR, ALKS, AZN, BBI
- Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts
Oct 19, 2009 10:24 PM | BMY, CLDA, CRGN, GSK, MEDX
- Our Outlook for Health-Care Stocks
Oct 01, 2009 07:00 PM | A, BMY, COV, DHR, GE, JNJ
- Access Pharma (OTC: ACCP.OB): MuGard, Pipeline Makes for Appealing Acquisition Possibilities
Sep 29, 2009 03:36 PM | ACCP, ALTH, BBI, BIIB, CTIC, MEDX
- Bristol-Myers Squibb Completes Tender Offer for Medarex, Inc.
Sep 01, 2009 08:10 AM | BMY, MEDX
- Partnerships And Mergers Updates : Wipro Partners with BP, Endo Buys US Rights to Fortesta, Siemens Buys China Metal, Google's Search for Italian Solution
Aug 28, 2009 02:15 PM | ABB, ADC, AUXL, BMY, ENDP, GE
- Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Medarex, Inc.
Aug 12, 2009 08:30 AM | BMY, MEDX
- The Big Picture on the Biotech Rally - NBI
Aug 07, 2009 03:35 PM | BBI, DNDN, HGSI, MEDX
- Is It The Right Time To Buy Biotechnology Investments?
Jul 30, 2009 03:44 PM | AMG, BIIB, CELG, GENZ, HGSI, LLY
- Catch These Stocks And You'll Never Have To Work Again
Jul 29, 2009 11:57 AM | BMY, DNA, MEDX, PFE
- Dow tops 9,000 as home sales rise for 3rd month
Jul 23, 2009 06:54 PM | AMZN, AXP, BMY, CAT, F, FII
- Ford, Safeway, EMC, Fifth Third are big movers
Jul 23, 2009 06:15 PM | DHI, EBAY, EMC, F, FITB, MEDX
- Strong sales boost Bristol-Myers 2Q profit
Jul 23, 2009 05:58 PM | BMY, LLY, MEDX
- Bristol-Myers, Wyeth turn in strong 2Q results
Jul 23, 2009 04:59 PM | BMY, LLY, MEDX, MRK, PFE, SGP
- Strong sales boost Bristol-Myers 2Q profit
Jul 23, 2009 01:00 PM | BMY, MEDX
- Stock futures hold on to gains after labor data
Jul 23, 2009 09:57 AM | AMZN, AXP, BMY, F, MEDX, MSFT
- Strong sales boost Bristol-Myers 2Q profit
Jul 23, 2009 09:57 AM | BMY, MEDX
- Stock futures push higher amid earnings, jobs data
Jul 23, 2009 09:56 AM | AMZN, BMY, F, MEDX, PM, WYE
- Stocks hold steady amid latest earnings
Jul 23, 2009 09:55 AM | AMZN, AXP, BMY, F, FII, GS
- Strong sales boost Bristol-Myers 2Q profit
Jul 23, 2009 07:52 AM | BMY, MEDX
- Bristol-Myers Squibb Completes Acquisition of Medarex, Inc.
Sep 01, 2009 05:56 PM | BMY, MEDX
- Bristol-Myers Squibb Completes Initial Tender Offer for Medarex, Inc. With 87.7% of Shares Tendered; Announces Subsequent Offering Period
Aug 27, 2009 09:55 AM | BMY, MEDX
- Bristol-Myers Squibb Extends Tender Offer for Medarex, Inc.
Aug 20, 2009 05:51 PM | BMY, MEDX
- BenchmarkJournal.Com Free Analyst Review for KERX, MEDX, AMCC, HBAN, JBLU and LNCR
Aug 11, 2009 10:20 AM | AMCC, HBAN, JBLU, KERX, LNCR, MEDX
- Brower Piven Announces the Filing of Class Action Lawsuit Against Medarex, Inc.
Aug 04, 2009 06:18 PM | MEDX
- Harwood Feffer LLP Files Class Action On Behalf of Shareholders of Medarex, Inc. -- MEDX
Jul 31, 2009 06:18 PM | MEDX
- Medarex Announces 2009 Second Quarter Financial Results
Jul 31, 2009 09:51 AM | BMY, MEDX, MRK
- Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.
Jul 28, 2009 06:06 AM | BMY, MEDX
- Fitch Expects Bristol-Myers Squibb's Ratings to Be Unaffected By Medarex Acquisition
Jul 23, 2009 02:58 PM | MEDX
- Bristol-Myers Squibb to Acquire Medarex
Jul 22, 2009 07:53 PM | BMY, MEDX
- Form 4 NICHOL GEOFFREY For: Sep 01 (10K)
Sep 03, 2009 06:07 PM
- Form 4 SCHADE CHRISTIAN S For: Sep 01 (10K)
Sep 03, 2009 05:42 PM
- Form 4 PEPIN RONALD For: Sep 01 (10K)
Sep 03, 2009 05:42 PM
- Form 4 LONBERG NILS For: Sep 01 (10K)
Sep 03, 2009 05:40 PM
- Form 4 Dietl Deanna For: Sep 01 (10K)
Sep 03, 2009 05:40 PM
- Form 4 Bartels Ursula B For: Sep 01 (10K)
Sep 03, 2009 05:40 PM
- Form 4 PIEN HOWARD H For: Sep 01 (10K)
Sep 03, 2009 05:39 PM
- Form 4 VIDA JULIUS A For: Sep 01 (10K)
Sep 03, 2009 05:39 PM
- Form 4 SCHALLER CHARLES R For: Sep 01 (10K)
Sep 03, 2009 05:38 PM
- Form 4 SALDARINI RONALD J For: Sep 01 (10K)
Sep 03, 2009 05:38 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MEDX
|
Compare to S&P
|
| YTD |
186.38 %
|
151.77 %
|
| 4 Weeks |
0.44 %
|
-3.87 %
|
| 12 Weeks |
113.35 %
|
95.03 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -6.25 %
|
|
EPS Growth in Last Year: 12.82 %
|
|
Sales Growth in Last Quarter: 79.95 %
|
|
Sales Growth in Last Quarter: 95.79 %
|
|
